Canada markets close in 34 minutes

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.7745+0.0245 (+3.27%)
As of 03:13PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 21.84M
Enterprise Value 11.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)23.81
Price/Book (mrq)2.75
Enterprise Value/Revenue 13.59
Enterprise Value/EBITDA -1.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3-31.82%
S&P500 52-Week Change 3-15.89%
52 Week High 32.6000
52 Week Low 30.6900
50-Day Moving Average 30.8036
200-Day Moving Average 30.9092

Share Statistics

Avg Vol (3 month) 370.89k
Avg Vol (10 day) 339.39k
Shares Outstanding 527.19M
Implied Shares Outstanding 6N/A
Float 827.18M
% Held by Insiders 10.00%
% Held by Institutions 11.82%
Shares Short (Nov 14, 2022) 4379.92k
Short Ratio (Nov 14, 2022) 43.15
Short % of Float (Nov 14, 2022) 4N/A
Short % of Shares Outstanding (Nov 14, 2022) 41.40%
Shares Short (prior month Oct 13, 2022) 4442.93k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 09, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3May 09, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,351.41%

Management Effectiveness

Return on Assets (ttm)-50.47%
Return on Equity (ttm)-134.49%

Income Statement

Revenue (ttm)817k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-18.70%
Gross Profit (ttm)853k
EBITDA -11.03M
Net Income Avi to Common (ttm)-13.86M
Diluted EPS (ttm)-0.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.81M
Total Cash Per Share (mrq)0.4
Total Debt (mrq)74k
Total Debt/Equity (mrq)1.00
Current Ratio (mrq)4.49
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A